Lion Street Advisors LLC Raises Position in General Mills, Inc. $GIS
Lion Street Advisors LLC significantly increased its stake in General Mills (NYSE:GIS) by 51.1% in the third quarter, making it their largest holding. While several institutional investors have adjusted their positions, analyst sentiment is mixed, with some firms lowering price targets due to concerns about growth prospects and a "challenging backdrop" despite positive views on the company's brand strength and dividend. Insider selling by Paul Joseph Gallagher was also noted, reducing his ownership by 3%.
Public Sector Pension Investment Board Lowers Position in Kimberly-Clark Corporation $KMB
The Public Sector Pension Investment Board significantly reduced its stake in Kimberly-Clark Corporation (NASDAQ:KMB) by 65.9% in the third quarter, selling 56,142 shares and holding 29,019 shares valued at $3.61 million. Despite this, other institutional investors increased their positions, and Kimberly-Clark recently announced an increased quarterly dividend of $1.28 per share, payable on April 2nd. The company reported strong Q3 earnings, beating analyst estimates, and maintained an average "Hold" rating from equities research analysts.
Assetmark Inc. Lowers Stock Holdings in Kenvue Inc. $KVUE
Assetmark Inc. reduced its stake in Kenvue Inc. by 49.3% in Q3, selling 53,749 shares and retaining 55,174 shares valued at approximately $895,000. Despite this reduction by Assetmark, other institutional investors have acquired new positions or increased their holdings in Kenvue. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $0.2075 per share, yielding 4.4%.
Kenvue Inc call volume above normal and directionally bullish
Kenvue Inc (KVUE) is experiencing significantly high call option volume, double the expected amount, indicating a directionally bullish sentiment among investors. The implied volatility for KVUE has also increased, and the put/call ratio is very low at 0.07. Earnings for Kenvue are anticipated on May 7th, and several analysts have recently raised their price targets for the stock.
Kenvue Inc. $KVUE Shares Bought by ICICI Prudential Asset Management Co Ltd
ICICI Prudential Asset Management Co Ltd significantly increased its stake in Kenvue Inc. by 137.9% in Q3, acquiring an additional 262,000 shares to own a total of 452,060 shares valued at approximately $7.34 million. This move is part of broader institutional investor activity, with other funds also adjusting their positions in Kenvue. The company recently exceeded quarterly earnings and revenue estimates and announced a quarterly dividend, while analysts currently hold a "Hold" consensus rating for the stock.
Kenvue Inc. $KVUE Shares Sold by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. reduced its stake in Kenvue Inc. (NYSE:KVUE) by 17.7% in the third quarter, selling 81,484 shares. Despite this, other institutional investors have recently increased their holdings in Kenvue. The article also notes significant insider buying, with Director Jeffrey C. Smith acquiring 3.2 million shares, and details the company's recent earnings, dividend announcement, and analyst ratings.
NEOS Investment Management LLC Purchases 24,149 Shares of General Mills, Inc. $GIS
NEOS Investment Management LLC increased its stake in General Mills by 44.6% in the third quarter, purchasing an additional 24,149 shares, bringing its total holdings to 78,258 shares valued at approximately $3.95 million. This coincides with other institutional investors, such as Vanguard Group Inc. and State Street Corp, also increasing their positions, resulting in institutional investors owning 75.71% of General Mills. The company's stock has recently faced price target reductions and rating downgrades from analysts due to a guidance cut and weaker demand, despite remaining an attractive option for income investors with a 5.4% dividend yield.
NEOS Investment Management LLC Acquires 79,835 Shares of Kenvue Inc. $KVUE
NEOS Investment Management LLC increased its stake in Kenvue Inc. by 49.3%, purchasing 79,835 additional shares, bringing its total holdings to 241,756 shares valued at $3.92 million. Insider Jeffrey C. Smith also made a significant purchase of 3.2 million shares, increasing his ownership to over 27 million shares. Kenvue currently holds an average "Hold" rating from analysts with a target price of $20.08, and pays a quarterly dividend of $0.2075, although it has a high payout ratio.
Kenvue Inc. SEC 10-K Report
Kenvue Inc. has released its annual 10-K report, detailing its financial and operational performance for the fiscal year, including decreased net sales but increased operating and net income. The report highlights strategic initiatives like the 'Vue Forward' program and a proposed merger with Kimberly-Clark, while also outlining challenges such as transaction, operational, regulatory, and market risks.
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Decreases Position in Kenvue Inc. $KVUE
BNP PARIBAS ASSET MANAGEMENT Holding S.A. decreased its stake in Kenvue Inc. by 9.3% in the third quarter, reducing its holdings to 722,929 shares valued at $11.73 million. Other institutional investors showed mixed activity, with some like CWM LLC and Allianz Asset Management GmbH increasing their positions, while collectively, institutional investors and hedge funds own 97.64% of Kenvue's stock. Kenvue recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of $0.2075 per share, resulting in an annualized dividend yield of 4.4%.
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Kenvue, Inc. (KVUE), Conagra Brands (CAG) and JBS (JBS)
Analysts have issued mixed opinions on several consumer goods stocks, with Kenvue, Inc. receiving a "Hold" rating from Barclays and William Blair. Conagra Brands was rated "Buy" by Barclays, while JBS also received "Buy" ratings from Barclays and UBS, representing a significant upside potential.
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Kenvue, Inc. (KVUE), Conagra Brands (CAG) and JBS (JBS)
Analysts have issued mixed opinions on several consumer goods stocks, with Kenvue, Inc. (KVUE) receiving a Hold rating from Barclays, Conagra Brands (CAG) securing a Buy rating from Barclays, and JBS (JBS) also getting a Buy rating from Barclays and UBS. The analysis includes price targets and highlights the consensus ratings for each company within the Consumer Goods sector.
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Kenvue, Inc. (KVUE), Conagra Brands (CAG) and JBS (JBS)
This article summarizes analysts' views on three consumer goods stocks: Kenvue, Inc. (KVUE), Conagra Brands (CAG), and JBS (JBS). Kenvue received a "Hold" rating from Barclays and William Blair, while Conagra Brands was rated "Buy" by Barclays and has a general "Hold" consensus. JBS garnered "Buy" ratings from Barclays and UBS, with analysts noting a "Strong Buy" consensus and significant upside potential.
Kenvue’s Results Slip In Final Standalone Year
Kenvue’s financial results for its final standalone year have shown a decline. The article, published on February 18, 2026, by Malcolm Spicer, suggests an analysis of these results within the broader context of the consumer health industry. It covers various related topics such as retail, M&A, OTC drugs, dietary supplements, cosmetics, and supply chain.
Kenvue Analysts Boost Their Forecasts After Upbeat Q4 Earnings
Kenvue (NYSE: KVUE) reported strong Q4 2025 earnings, surpassing analyst estimates with 27 cents per share and $3.780 billion in sales. This upbeat performance led to a 2.4% rise in Kenvue shares and prompted analysts from UBS and Citigroup to raise their price targets for the stock. The company's CEO, Kirk Perry, attributed the success to disciplined execution and a favorable comparison to the previous year, with a focus on enhancing performance and completing the combination with Kimberly-Clark in 2026.
UBS raises Kenvue stock price target to $19 on Q4 beat
UBS has increased its price target for Kenvue Inc (NYSE:KVUE) to $19 from $17, while maintaining a Neutral rating on the stock, following Kenvue's better-than-expected fourth-quarter results. The improved outlook is attributed to strong organic sales growth, better gross and operating margins, and a favorable tax rate, despite investor sentiment initially being negative. Kenvue's future trajectory is influenced by its pending acquisition by Kimberly-Clark, and it offers a 4.51% dividend yield for income-focused investors.
Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal
Kenvue (KVUE) surpassed Q4 earnings and revenue estimates, driven by organic growth and improved margins, despite some volume softness. The company's performance was strong in Essential Health, and Skin Health and Beauty segments, across various regions outside North America. Kenvue is also moving forward with its planned acquisition by Kimberly-Clark, with key approvals already secured and closure expected in the second half of 2026.
Waycross Partners LLC Purchases New Stake in Kenvue Inc. $KVUE
Waycross Partners LLC has acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 200,000 shares valued at approximately $3.25 million in the third quarter. This comes as Kenvue exceeded Q4 earnings and revenue estimates but also announced a workforce reduction and faces concerns about operating cash flow. Notably, a director, Jeffrey C. Smith, significantly increased his holdings, signaling insider confidence despite mixed market sentiment.
Vanguard Group Inc. Raises Stake in Kenvue Inc. $KVUE
Vanguard Group Inc. significantly increased its stake in Kenvue Inc. by acquiring an additional 101,177 shares, bringing its total ownership to 233,347,444 shares, valued at approximately $3.79 billion. Concurrently, Kenvue Director Jeffrey C. Smith purchased 3.2 million shares, increasing his personal holdings, while the company reported better-than-expected Q4 earnings with $3.78 billion in revenue and $0.27 EPS, declared a quarterly dividend, and announced workforce reductions. Despite the positive earnings, analysts hold a consensus "Hold" rating with an average price target of $19.46, and the company plans restructuring ahead of a proposed deal with Kimberly-Clark.
BofA Securities resumes Kenvue stock coverage with no rating
BofA Securities has resumed coverage of Kenvue Inc (NYSE:KVUE) with no rating, citing the company's pending acquisition by Kimberly-Clark. Despite reporting fourth-quarter organic sales growth and impressive gross profit margins, Kenvue's stock is not trading on fundamentals due to the impending acquisition. The consumer health company, valued at $35.27 billion, operates with moderate debt and offers a 4.51% dividend yield.
Is Kenvue (KVUE) Attractively Priced After Spin Off From Johnson & Johnson?
Kenvue (KVUE) is analyzed for its valuation after spinning off from Johnson & Johnson. A Discounted Cash Flow (DCF) analysis suggests KVUE is undervalued by 38.2% at US$18.41, with an intrinsic value of US$29.77. However, its Price-to-Earnings (P/E) ratio of 24.6x is above industry and peer averages, suggesting it might be overvalued based on earnings.
Aberdeen Group plc Acquires 644,930 Shares of Kenvue Inc. $KVUE
Aberdeen Group plc significantly increased its stake in Kenvue Inc. (NYSE:KVUE) by 84.1%, acquiring an additional 644,930 shares, bringing its total to 1,411,380 shares valued at approximately $22.9 million. This comes as Kenvue beat Q4 earnings and revenue estimates, reporting $0.27 EPS and $3.78 billion in revenue, and announced a quarterly dividend. However, the company's high payout ratio and recent workforce reductions are noted as potential concerns, while institutional investors like CWM LLC and Allianz Asset Management GmbH also modified their holdings.
Stocks to Watch Wednesday: Palo Alto Networks, Synopsys, Moody's, Kenvue
This article highlights several stocks to watch, including Moderna, which saw a significant jump after the FDA agreed to review its flu shot, and Analog Devices, which reported strong quarterly results. Sandisk also experienced a slight increase following Western Digital's plan to sell shares.
Stocks to Watch Wednesday: Palo Alto Networks, Analog Devices, Kenvue
Palo Alto Networks reported better-than-expected quarterly results and raised its annual revenue outlook, but lower-than-expected earnings-per-share guidance for the current quarter led to a 7.5% drop in premarket trading. Caesars Entertainment saw its shares gain 4% in off-hours trading after reporting higher-than-forecast quarterly revenue despite swinging to a loss. Kenvue exceeded quarterly result forecasts and announced a 3.5% staff reduction ahead of its planned takeover by Kimberley-Clark.
Stocks to Watch Wednesday: Palo Alto Networks, Sandisk, Kenvue
This article highlights key stocks to watch on Wednesday, focusing on Analog Devices, Palo Alto Networks, and Sandisk. Analog Devices saw its stock rally after exceeding quarterly expectations, while Palo Alto Networks dropped in premarket trading despite raising its annual revenue outlook, due to disappointing EPS guidance. Sandisk shares also fell after its former parent company, Western Digital, announced plans to sell shares in the flash-memory supplier.
Stocks to Watch Wednesday: Palo Alto Networks, Moody's, Caesars
This article highlights several stocks to watch on Wednesday, featuring Palo Alto Networks, Moody's, and Kenvue. Moderna's shares jumped after the FDA agreed to review its seasonal flu shot, while Analog Devices rose on strong quarterly results and guidance. Conversely, Palo Alto Networks saw its shares drop despite better-than-expected earnings, due to disappointing earnings-per-share guidance for the current quarter.
Starboard Value raises stakes in Kenvue, Riot Platforms By Reuters
Activist investor Starboard Value LP increased its holdings in cryptocurrency firm Riot Platforms and consumer health company Kenvue during the December quarter. Concurrently, the firm reduced its stakes in Rogers Corp, News Corp, Salesforce, and Autodesk. Starboard also plans to push for a major overhaul of Tripadvisor's board, preparing to nominate a majority slate.
Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition
Kenvue exceeded quarterly earnings estimates and announced job cuts, following its acquisition of several non-core brands from Kimberly-Clark. The company's fourth-quarter net sales reached $3.6 billion, driven by strong growth in its self-care and essential health segments, and it also initiated a restructuring program to streamline operations.
Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition
Kenvue exceeded Wall Street expectations for its fourth-quarter results and revealed plans for a global workforce reduction of about 3.5% as it moves forward with its acquisition by Kimberly-Clark. The Tylenol-maker reported strong performance in its self-care and essential health segments, with net sales and adjusted profit per share beating analyst estimates. These job cuts are expected to lead to approximately $250 million in pre-tax restructuring expenses in 2026.
Earnings Flash (KVUE) Kenvue Inc. Posts Q4 Adjusted EPS $0.27 per Share, vs. FactSet Est of $0.22
Kenvue Inc. (KVUE) announced its Q4 adjusted EPS was $0.27 per share, surpassing the FactSet estimate of $0.22. Additionally, the company reported Q4 revenue of $3.78 billion, which also exceeded the FactSet estimate of $3.68 billion. This positive financial performance indicates stronger-than-expected results for the consumer healthcare products leader.
Kenvue (NYSE:KVUE) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold Kenvue (NYSE:KVUE) shares valued between $1,001 and $15,000 on January 9th. This disclosure came amidst Kenvue beating its quarterly earnings estimates and announcing a quarterly dividend. Analyst ratings for Kenvue are predominantly "Hold," with an average price target of $19.46.
Consumer goods giant Kenvue Inc recently announced a major strategic adjustment plan.
Kenvue Inc, a consumer goods giant, has announced a strategic adjustment plan expected to incur approximately $250 million in pre-tax restructuring costs in fiscal year 2026. This initiative aims to optimize the company's operations, enhance long-term competitiveness through resource integration, and build a more agile organizational system. Despite short-term expenditures, the company believes this will establish a solid foundation for future growth in an evolving global consumer market.
Kenvue: Q4 Earnings Snapshot
Kenvue Inc. reported strong fourth-quarter results, with profits of $330 million and adjusted earnings of 27 cents per share, surpassing Wall Street expectations. The consumer health company also exceeded revenue forecasts, posting $3.78 billion for the quarter. For the full year, Kenvue reported a profit of $1.47 billion and revenue of $15.12 billion.
Kenvue Reports Fourth Quarter and Full Year 2025 Results
Kenvue Inc. announced its financial results for the fourth quarter and full year ended December 28, 2025. The company reported increased net sales and organic sales in Q4 2025, with adjusted diluted EPS of $0.27, reflecting stronger top- and bottom-line performance. For the full year, net sales declined slightly, and adjusted diluted EPS was $1.08. The report also detailed progress on its pending acquisition by Kimberly-Clark, with the transaction expected to close in the second half of 2026.
Kenvue (NYSE: KVUE) details 2025 results, $250M restructuring and Kimberly-Clark deal progress
Kenvue Inc. announced its full-year 2025 financial results, reporting a decline in net sales and organic sales but an increase in diluted EPS. The company also detailed a new restructuring initiative expected to cut its global workforce by 3.5% and result in $250 million in pre-tax charges for fiscal year 2026. Additionally, Kenvue provided updates on its pending acquisition by Kimberly-Clark, noting shareholder approvals and U.S. antitrust clearance, with closing anticipated in the second half of 2026.
Kenvue Reports Fourth Quarter and Full Year 2025 Results
Kenvue Inc. announced its financial results for the fiscal fourth quarter and full year ended December 28, 2025, showing strong top- and bottom-line performance in the fourth quarter. The company attributes its success to disciplined execution against strategic priorities and a favorable year-ago comparison on sales, as stated by CEO Kirk Perry. Kenvue also confirmed its pending acquisition by Kimberly-Clark, which received overwhelming shareholder approval in January 2026 and is expected to close in the second half of 2026, subject to regulatory approvals.
Kenvue Reports Fourth Quarter and Full Year 2025 Results
Kenvue Inc. announced its financial results for the fourth quarter and full year ended December 28, 2025, showing improved performance with Q4 net sales up 3.2% and organic sales growing by 1.2%. The company reported diluted EPS of $0.17 for Q4 and $0.76 for the full year 2025. Kenvue also provided an update on its pending acquisition by Kimberly-Clark, which is expected to close in the second half of 2026, and confirmed it will not provide forward-looking guidance due to this transaction.
After Hours Most Active for Feb 17, 2026 : PBPH, PBOG, AAPL, EUFN, PBEU, NVDA, KVUE, B, T, CVE, PCG, NU
This report details the most active stocks in after-hours trading on February 17, 2026. Key movers include PBPH, PBOG, AAPL, EUFN, PBEU, NVDA, KVUE, B, T, CVE, PCG, and NU, with some showing significant gains from their 52-week lows and others having recent earnings forecast revisions. The NASDAQ 100 After Hours Indicator was down, with a total volume of over 291 million shares traded.
Kenvue Inc options imply 3.7% move in share price post-earnings
Options trading for Kenvue Inc (KVUE) suggests a potential 3.7% share price movement, or 69 cents, following its upcoming earnings release. While options volume is normal with calls leading puts 5:4, the implied volatility indicates a market expectation for this movement. This anticipated move is slightly below the stock's median movement of 4.9% observed over the past eight quarters post-earnings.
Kenvue (KVUE) Beats Q4 Earnings and Revenue Estimates
Kenvue (KVUE) significantly surpassed Q4 earnings and revenue estimates, reporting $0.27 per share against an estimated $0.22, and revenues of $3.78 billion which exceeded the $3.71 billion consensus. The company has consistently beaten EPS estimates over the last four quarters. Despite outperforming the market year-to-date, Kenvue currently holds a Zacks Rank #3 (Hold) based on mixed estimate revisions.
Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition
Kenvue, the Tylenol-maker, exceeded Wall Street's fourth-quarter revenue and profit estimates and announced a 3.5% global workforce reduction. This move comes as the company prepares for a planned acquisition by Kimberly-Clark, which is expected to close in the second half of 2026. The job cuts are anticipated to result in approximately $250 million in pre-tax restructuring expenses in 2026.
Kenvue earnings on deck as Kimberly-Clark merger looms
Kenvue Inc. is set to announce its fourth-quarter results, with investor attention focused more on its impending $48.7 billion acquisition by Kimberly-Clark than its operational performance. Analysts expect EPS of $0.33 and revenue of $4.11 billion, showing sequential improvements. However, with the merger approved by shareholders and the stock trading near the implied deal value, quarterly results are unlikely to significantly impact the stock price, as the company will not host a conference call due to the pending transaction.
KVUE stock edges up in premarket as Kenvue earnings and Kimberly-Clark deal math take over
Kenvue (KVUE) stock is up slightly in premarket trading as the company prepares to release its Q4 earnings, though without a conference call due to its pending acquisition by Kimberly-Clark (KMB). The all-stock-and-cash deal implies a value of $19.50 per Kenvue share, leaving a 4% spread that merger arbitrage funds are closely monitoring. The acquisition is expected to close in the latter half of 2026, pending regulatory approvals, and shareholder votes have already approved the deal.
Mondrian Investment Partners LTD Takes Position in Kenvue Inc. $KVUE
Mondrian Investment Partners LTD has acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing over 4.8 million shares valued at approximately $79.27 million, representing about 0.25% of the company. Other institutional investors have also adjusted their positions, and Director Jeffrey C. Smith recently bought 3.2 million shares, increasing his holding to 27.3 million shares. Kenvue has declared a quarterly dividend of $0.2075, leading to an annualized dividend of $0.83 and a yield of around 4.4%.
Crestwood Advisors Group LLC Cuts Holdings in Kenvue Inc. $KVUE
Crestwood Advisors Group LLC reduced its stake in Kenvue Inc. (NYSE:KVUE) by 35.2% during the third quarter, selling over 500,000 shares. Despite this, Kenvue's director Jeffrey C. Smith acquired 3.2 million shares, indicating significant insider buying. The company also declared a quarterly dividend of $0.2075, offering a 4.4% yield, though its high payout ratio may raise sustainability concerns.
Cadence Design, Palo Alto Networks, Kenvue to report earnings Tuesday
Cadence Design, Palo Alto Networks, and Kenvue are among several major companies scheduled to report earnings on Tuesday. The article provides a comprehensive list of companies reporting before market open and after market close, including their estimated EPS and revenue figures to help investors prepare for the upcoming earnings season.
Cadence Design, Palo Alto Networks, Kenvue to report earnings Tuesday
This article lists companies scheduled to report earnings on the upcoming Tuesday, highlighting key technology firms Cadence Design System and Palo Alto Networks, as well as healthcare product leader Kenvue. It provides detailed EPS and revenue estimates for numerous companies reporting both before and after market open, offering investors a comprehensive overview for the earnings season.
M&G PLC Lowers Position in Kenvue Inc. $KVUE
M&G PLC has reduced its stake in Kenvue Inc. (NYSE:KVUE) by 1.8%, now owning 8,030,140 shares valued at $128.48 million. Despite this, institutional investors collectively hold a significant 97.64% of the company. Kenvue recently declared a quarterly dividend of $0.2075 per share, yielding 4.4% annually, and its stock is currently rated as a "Hold" by analysts with an average price target of $19.46.
Caprock Group LLC Buys New Stake in Kenvue Inc. $KVUE
Caprock Group LLC has acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 63,662 shares valued at approximately $1.03 million. This comes as other institutional investors have also adjusted their positions, with institutional ownership now at 97.64%. Despite a director's significant insider purchase of 3.2 million shares and a declared quarterly dividend of $0.2075 per share, analysts largely maintain a "Hold" rating for Kenvue, with a consensus target price of $19.46.
KVUE Kenvue Inc. (NYSE) pre-market Feb 16, 2026 earnings preview: catalysts ahead
Kenvue Inc. (KVUE) is previewed ahead of its Q4 earnings report on February 17, 2026, with its stock trading at $18.70 pre-market. Investors will focus on revenue mix, margin recovery, and management guidance, particularly in Self Care, Skin Health, and Essential Health segments. Meyka AI rates KVUE with a B+ (Buy suggestion) and projects a near-term upside to $21.36, but also flags potential downside scenarios depending on the earnings call.
